Ankyrin-2 (ANK2)

The protein contains 3957 amino acids for an estimated molecular weight of 433715 Da.

 

Plays an essential role in the localization and membrane stabilization of ion transporters and ion channels in several cell types, including cardiomyocytes, as well as in striated muscle cells. In skeletal muscle, required for proper localization of DMD and DCTN4 and for the formation and/or stability of a special subset of microtubules associated with costameres and neuromuscular junctions. In cardiomyocytes, required for coordinate assembly of Na/Ca exchanger, SLC8A1/NCX1, Na/K ATPases ATP1A1 and ATP1A2 and inositol 1,4,5-trisphosphate (InsP3) receptors at sarcoplasmic reticulum/sarcolemma sites. Required for expression and targeting of SPTBN1 in neonatal cardiomyocytes and for the regulation of neonatal cardiomyocyte contraction rate (PubMed:12571597). In the inner segment of rod photoreceptors, required for the coordinated expression of the Na/K ATPase, Na/Ca exchanger and beta-2-spectrin (SPTBN1) (By similarity). Plays a role in endocytosis and intracellular protein transport. Associates with phosphatidylinositol 3-phosphate (PI3P)-positive organelles and binds dynactin to promote long-range motility of cells. Recruits RABGAP1L to (PI3P)-positive early endosomes, where RABGAP1L inactivates RAB22A, and promotes polarized trafficking to the leading edge of the migrating cells. Part of the ANK2/RABGAP1L complex which is required for the polarized recycling of fibronectin receptor ITGA5 ITGB1 to the plasma membrane that enables continuous directional cell migration (By simi (updated: Dec. 5, 2018)

Protein identification was indicated in the following studies:

  1. Goodman and co-workers. (2013) The proteomics and interactomics of human erythrocytes. Exp Biol Med (Maywood) 238(5), 509-518.
  2. Lange and co-workers. (2014) Annotating N termini for the human proteome project: N termini and Nα-acetylation status differentiate stable cleaved protein species from degradation remnants in the human erythrocyte proteome. J Proteome Res. 13(4), 2028-2044.
  3. Hegedűs and co-workers. (2015) Inconsistencies in the red blood cell membrane proteome analysis: generation of a database for research and diagnostic applications. Database (Oxford) 1-8.
  4. Bryk and co-workers. (2017) Quantitative Analysis of Human Red Blood Cell Proteome. J Proteome Res. 16(8), 2752-2761.
  5. D'Alessandro and co-workers. (2017) Red blood cell proteomics update: is there more to discover? Blood Transfus. 15(2), 182-187.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

This protein is annotated as membranous in Gene Ontology, is annotated as membranous in UniProt.


Interpro domains
Total structural coverage: 19%
Model score: 0
No model available.

(right-click above to access to more options from the contextual menu)

VariantDescription
a breast cancer sample; somatic mutation
dbSNP:rs29372
a colorectal cancer sample; somatic mutation
LQT4
dbSNP:rs28377576
a colorectal cancer sample; somatic mutation
LQT4
LQT4
LQT4
LQT4
empty

Biological Process

Atrial cardiac muscle cell action potential GO Logo
Atrial cardiac muscle cell to AV node cell communication GO Logo
Atrial septum development GO Logo
Axon guidance GO Logo
Cardiac muscle contraction GO Logo
Cellular calcium ion homeostasis GO Logo
Cellular protein localization GO Logo
Endocytosis GO Logo
Endoplasmic reticulum to Golgi vesicle-mediated transport GO Logo
Membrane depolarization during SA node cell action potential GO Logo
Paranodal junction assembly GO Logo
Positive regulation of calcium ion transmembrane transporter activity GO Logo
Positive regulation of calcium ion transport GO Logo
Positive regulation of cation channel activity GO Logo
Positive regulation of gene expression GO Logo
Positive regulation of potassium ion transmembrane transporter activity GO Logo
Positive regulation of potassium ion transport GO Logo
Protein localization to cell surface GO Logo
Protein localization to endoplasmic reticulum GO Logo
Protein localization to M-band GO Logo
Protein localization to organelle GO Logo
Protein localization to plasma membrane GO Logo
Protein localization to T-tubule GO Logo
Protein stabilization GO Logo
Protein targeting to plasma membrane GO Logo
Protein transport GO Logo
Regulation of atrial cardiac muscle cell action potential GO Logo
Regulation of calcium ion transmembrane transporter activity GO Logo
Regulation of calcium ion transport GO Logo
Regulation of cardiac muscle cell contraction GO Logo
Regulation of cardiac muscle cell membrane potential GO Logo
Regulation of cardiac muscle contraction GO Logo
Regulation of cardiac muscle contraction by calcium ion signaling GO Logo
Regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion GO Logo
Regulation of heart rate GO Logo
Regulation of heart rate by cardiac conduction GO Logo
Regulation of protein stability GO Logo
Regulation of release of sequestered calcium ion into cytosol GO Logo
Regulation of SA node cell action potential GO Logo
Regulation of ventricular cardiac muscle cell membrane repolarization GO Logo
Response to methylmercury GO Logo
SA node cell action potential GO Logo
SA node cell to atrial cardiac muscle cell communication GO Logo
Sarcoplasmic reticulum calcium ion transport GO Logo
T-tubule organization GO Logo
Ventricular cardiac muscle cell action potential GO Logo

The reference OMIM entry for this protein is 106410

Ankyrin 2; ank2
Ankyrin, nonerythroid
Ankyrin, brain
Ankyrin, neuronal
Ankyrin-b

CLONING

Tse et al. (1991) studied immunoreactive isoforms of erythrocyte ankyrin found in nonerythroid tissues. Using an erythrocyte ankyrin cDNA clone as a hybridization probe, they isolated a clone from a human genomic library that hybridized at low but not at high stringency. Further studies suggested that the clone represented part of a gene for nonerythroid ankyrin, which they designated ANK2. Otto et al. (1991) isolated and sequenced cDNAs related to 2 brain ankyrin isoforms and showed that they are produced through alternative splicing of the mRNA from a single gene.

GENE STRUCTURE

The ANK2 gene contains 46 exons (Mohler et al., 2007). Exon 38 is brain-specific.

GENE FUNCTION

The axon initial segment (AIS) is the site at which neural signals arise, and should be the most efficient site to regulate neural activity. Kuba et al. (2010) reported that deprivation of auditory input in an avian brainstem auditory neuron leads to an increase in AIS length, thus augmenting the excitability of the neuron. The length of the AIS, defined by the distribution of voltage-gated sodium channels and the AIS anchoring protein, ankyrin G, increased by 1.7 times in 7 days after auditory input deprivation. This was accompanied by an increase in the whole-cell sodium current, membrane excitability, and spontaneous firing. Kuba et al. (2010) concluded that their work demonstrated homeostatic regulations of the AIS, which may contribute to the maintenance of the auditory pathway after hearing loss. Furthermore, plasticity at the spike initiation site suggests a powerful pathway for refining neuronal computation in the face of strong sensory deprivation.

MAPPING

By analysis of somatic cell hybrids and by fluorescence in situ hybridization, Tse et al. (1991) assigned the ANK2 gene to 4q25-q27. By analysis of human/rodent cell hybrids, Otto et al. (1991) assigned the brain ankyrin gene to chromosome 4.

MOLECULAR GENETICS

Schott et al. (1995) characterized a large French kindred with long QT syndrome associated with sinus node dysfunction and episodes of atrial fibrillation segregating as an autosomal dominant trait. They mapped the disorder to an 18-cM interval on 4q25-q27 (LQT4; 600919). Mohler et al. (2003) sequenced the ANK2 gene, which maps to the same region, and identified a glu1425-to-gly (E1425G) missense mutation (106410.0001). Ankyrin-B appears to be the first identified protein to be implicated in a congenital long QT syndrome that is not an ion channel or channel subunit. Mohler et al. (2004) identified 8 unrelated probands harboring 5 different ankyrin-B loss-of-function mutations (106410.0001-106410.0005), 4 of which were previously undescribed, and expanded the phenotype previously described by Schott et al. (1995). Mohler et al. (2004) found that humans with ankyrin-B mutations display varying degrees of cardiac dysfunction, including bradycardia, sinus arrhythmia, idiopathic ventricular fibrillation, catecholaminergic polymorphic ventricular tachycardia, and risk of sudden death. However, a prolonged rate-corrected QT interval was not a consistent feature, indicating that ankyrin-B dysfunction represents a clinical entity distinct from classic long QT syndromes. The mutations were localized in the ankyrin-B regulatory domain, which distinguishes function of ankyrin-B from ankyrin-G (ANK3; 600465) in cardiomyocytes. All mutations abolished ability of ankyrin-B to restore abnormal Ca(2+) ... More on the omim web site

Subscribe to this protein entry history

Dec. 9, 2018: Protein entry updated
Automatic update: Entry updated from uniprot information.

Feb. 5, 2018: Protein entry updated
Automatic update: Entry updated from uniprot information.

Feb. 2, 2018: Protein entry updated
Automatic update: Uniprot description updated

Dec. 19, 2017: Protein entry updated
Automatic update: Uniprot description updated

Nov. 23, 2017: Protein entry updated
Automatic update: Uniprot description updated

March 25, 2017: Additional information
No protein expression data in P. Mayeux work for ANK2

March 16, 2016: Protein entry updated
Automatic update: OMIM entry 106410 was added.

Jan. 27, 2016: Protein entry updated
Automatic update: model status changed

Jan. 24, 2016: Protein entry updated
Automatic update: model status changed